#breast cancer — Friday, July 24, 2026 (1 items)
| 0 | 💬 0 |
Enzymatic activity-independent NANS stabilizes LATS2 to drive growth and therapeutic resistance in HR+/HER2- breast cancer.
(nature.com)
|
Nature Communications 2026-07-24 | #breast cancer #drug resistance #protein stability #signaling-pathways #endocrine therapy |